OBJECTIVE: Cognitive impairments are common sequelae of traumatic brain injury (TBI) and are often associated with the natural process of aging. Few studies have examined the effect of both age and TBI on cognitive functioning. The purpose of this study was to compare cognitive functioning between older adults who sustained a TBI to an age-matched group of individuals without a brain injury and to determine whether the presence or absence of a genetic marker apolipoprotein epsilon (APOEepsilon4 allele) accounts for additional cognitive decline in both groups examined. METHODS AND PROCEDURES: Cognitive performance was measured by 11 neuropsychological tests, in 54 adults with TBI aged 55 and older and 40 age-matched control participants. All participants were reexamined 2 to 5 years later. SETTING: Community volunteer-based sample examined at a large, urban medical center. MAIN OUTCOME MEASURE(S): California Verbal Learning Test; Wechsler Memory Scale-III (Logical Memory I & II; Visual Reproduction I & II); Grooved Pegboard; Woodcock-Johnson Test of Cognitive Ability (Visual Matching and Cross-out); Wisconsin Card Sorting Test; Trail Making Test A & B; Conners' Continuous Performance Task; Wechsler Adult Intelligence Scale-III (Vocabulary); Controlled Oral Word Association Test; and Boston Naming Test. RESULTS: Participants with TBI had lower scores on tests of attention and verbal memory than did participants with no disability. Neither group exhibited a significant decline in cognitive function over time. The presence of the APOEepsilon4 allele did not account for additional decline in cognitive function in either group. CONCLUSION(S): The findings suggest that older adults with TBI may not be at increased risk for cognitive decline over short time periods (2 to 5 years) even if they are carriers of the APOEepsilon4 allele.
OBJECTIVE:Cognitive impairments are common sequelae of traumatic brain injury (TBI) and are often associated with the natural process of aging. Few studies have examined the effect of both age and TBI on cognitive functioning. The purpose of this study was to compare cognitive functioning between older adults who sustained a TBI to an age-matched group of individuals without a brain injury and to determine whether the presence or absence of a genetic marker apolipoprotein epsilon (APOEepsilon4 allele) accounts for additional cognitive decline in both groups examined. METHODS AND PROCEDURES: Cognitive performance was measured by 11 neuropsychological tests, in 54 adults with TBI aged 55 and older and 40 age-matched control participants. All participants were reexamined 2 to 5 years later. SETTING: Community volunteer-based sample examined at a large, urban medical center. MAIN OUTCOME MEASURE(S): California Verbal Learning Test; Wechsler Memory Scale-III (Logical Memory I & II; Visual Reproduction I & II); Grooved Pegboard; Woodcock-Johnson Test of Cognitive Ability (Visual Matching and Cross-out); Wisconsin Card Sorting Test; Trail Making Test A & B; Conners' Continuous Performance Task; Wechsler Adult Intelligence Scale-III (Vocabulary); Controlled Oral Word Association Test; and Boston Naming Test. RESULTS:Participants with TBI had lower scores on tests of attention and verbal memory than did participants with no disability. Neither group exhibited a significant decline in cognitive function over time. The presence of the APOEepsilon4 allele did not account for additional decline in cognitive function in either group. CONCLUSION(S): The findings suggest that older adults with TBI may not be at increased risk for cognitive decline over short time periods (2 to 5 years) even if they are carriers of the APOEepsilon4 allele.
Authors: Kristen Dams-OʼConnor; Joshua B Cantor; Margaret Brown; Marcel P Dijkers; Lisa A Spielman; Wayne A Gordon Journal: J Head Trauma Rehabil Date: 2014 Nov-Dec Impact factor: 2.710
Authors: Allison R Kaup; Carrie Peltz; Kimbra Kenney; Joel H Kramer; Ramon Diaz-Arrastia; Kristine Yaffe Journal: J Int Neuropsychol Soc Date: 2016-10-04 Impact factor: 2.892
Authors: Coleen M Atkins; M Cristina Falo; Ofelia F Alonso; Helen M Bramlett; W Dalton Dietrich Journal: Neurosci Lett Date: 2009-05-03 Impact factor: 3.046
Authors: Nadia Postupna; Shannon E Rose; Laura E Gibbons; Natalie M Coleman; Leanne L Hellstern; Kayla Ritchie; Angela M Wilson; Eiron Cudaback; Xianwu Li; Erica J Melief; Allison E Beller; Jeremy A Miller; Amber L Nolan; Desiree A Marshall; Rod Walker; Thomas J Montine; Eric B Larson; Paul K Crane; Richard G Ellenbogen; Edward S Lein; Kristen Dams-O'Connor; C Dirk Keene Journal: Front Neurol Date: 2021-03-16 Impact factor: 4.003